Milton C. Ault III - 15 Jun 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
15 Jun 2021
Net transactions value
+$10,000,000
Form type
4
Filing time
17 Jun 2021, 16:31:07 UTC
Previous filing
14 Jun 2021
Next filing
22 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $10,000,000 +2,000,000 +65% $5.00* 5,094,555 15 Jun 2021 By Digital Power Lending, LLC F1
transaction ALZN Common Stock Conversion of derivative security $0 +15,000,000 $0.000000 15,000,000 17 Jun 2021 By Ault Life Sciences, Inc. F2
holding ALZN Common Stock 10,000,000 15 Jun 2021 By Ault Life Sciences Fund, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Series A Convertible Preferred Stock Conversion of derivative security -750,000 -100% 0 17 Jun 2021 Common Stock 15,000,000 By Ault Life Sciences, Inc. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
F2 The 15,000,000 shares of Common Stock were issued to Ault Life Sciences, Inc. ("ALS") upon the conversion of the 750,000 shares of the Issuer's Series A Convertible Preferred Stock (the "Series A Preferred Stock") owned by ALS, which conversion occurred automatically upon the closing of the Issuer's initial public offering without payment of further consideration. Mr. Ault has sole voting and investment power with respect to the shares of Series A Preferred Stock held of record by ALS.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.